Effect of canagliflozin, a sodium–glucose cotransporter 2 inhibitor, on measurement of serum 1,5‐anhydroglucitol (坎格列净，一种钠‐葡萄糖共转运体2抑制剂，对血清1,5‐脱水葡萄糖醇测定的影响)-Reference-Cited by-同舟云学术

Effect of canagliflozin, a sodium–glucose cotransporter 2 inhibitor, on measurement of serum 1,5‐anhydroglucitol (坎格列净，一种钠‐葡萄糖共转运体2抑制剂，对血清1,5‐脱水葡萄糖醇测定的影响)

Published:2014-02-25 Issue:4 Volume:6 Page:378-380
ISSN:1753-0393
Container-title:Journal of Diabetes
language:en
Short-container-title:Journal of Diabetes

Author:

Balis Dainius A.¹,Tong Cindy¹,Meininger Gary¹

Affiliation:

1. Janssen Research & Development, LLC Raritan New Jersey USA

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1753-0407.12116

Reference13 articles.

1. Serum 1,5-Anhydroglucitol (GlycoMark™): A Short-Term Glycemic Marker

2. Circulating 1,5-Anhydroglucitol Levels in Adult Patients With Diabetes Reflect Longitudinal Changes of Glycemia

3. Comparison of metabolic effects of pioglitazone, metformin, and glimepiride over 1 year in Japanese patients with newly diagnosed Type 2 diabetes

4. Role of Sodium-Glucose Cotransporter 2 (SGLT 2) Inhibitors in the Treatment of Type 2 Diabetes

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 1,5-Anhydroglucitol: A Novel Biomarker of Adherence to Sodium–Glucose Cotransporter 2 Inhibitors;Diabetes Care;2023-12-13

2. Improved dissolution and pharmacokinetics of insufficiently water-soluble canagliflozin in solid dispersions with gelucire 50/13 as a drug carrier;2023-11-02

3. Current updates on metabolites and its interlinked pathways as biomarkers for diabetic kidney disease: A systematic review;Translational Research;2023-11

4. Dispersion of serum 1,5 anhydroglucitol values in patients with type 2 diabetes at goal of HbA1c;Diabetes Research and Clinical Practice;2023-05

5. The clinical impact of serum 1,5-anhydro-D-glucitol levels on coronary artery calcification and adverse outcomes assessed by coronary optical coherence tomography in diabetic patients;Frontiers in Cardiovascular Medicine;2022-08-30